Nanomedicine in cancer therapy: Advancing precision treatments

The progress made in the field of nanotechnology has resulted in the development of nanomedicine agents, which have demonstrated their efficacy as a promising clinical tool in the fight against different types of cancers. Furthermore, Nanomedicine products possess the potential to achieve intricate...

Full description

Saved in:
Bibliographic Details
Published inAdvances in biomarker sciences and technology Vol. 6; pp. 105 - 119
Main Authors Aborode, Abdullahi Tunde, Oluwajoba, Ayomide Samson, Ibrahim, Aminat Modupe, Ahmad, Shahzaib, Mehta, Aashna, Osayawe, Osasere Jude-Kelly, Oyebode, Damilola, Akinsola, Oluwaseun, Osinuga, Abraham, Onifade, Isreal Ayobami, Adelakun, Ibrahim O., Adesola, Ridwan Olamilekan, Abidola, Taiwo Bakare, Ogunyemi, Adedeji Daniel, Ogundijo, Oluwaseun Adeolu, Banwo, Olamilekan Gabriel, Obiechefu, Chibuzo H.
Format Journal Article
LanguageEnglish
Published Berkeley Elsevier B.V 2024
KeAi Publishing Communications Ltd
KeAi Communications Co. Ltd
Subjects
Breast cancer
Cancer therapies
Cancer therapy
Chemotherapy
Diagnostics
Drug delivery
Drugs
Lipids
Lung cancer
Medical diagnosis
Nanomaterials
Nanoparticles
Nanotechnology
Photodynamic therapy
Prostate cancer
Quantum dots
Therapeutics
Toxicity
Nanoparticles
Drug delivery
Diagnostics
Cancer therapy
Therapeutics
Online AccessGet full text

Cover

More Information
Summary:The progress made in the field of nanotechnology has resulted in the development of nanomedicine agents, which have demonstrated their efficacy as a promising clinical tool in the fight against different types of cancers. Furthermore, Nanomedicine products possess the potential to achieve intricate targeting strategies and multifunctionality. Currently, nanoparticles possess diverse applications across various scientific disciplines and serve as a crucial component in contemporary medical practices. The specimens have undergone analysis for diverse clinical purposes, including serving as drug carriers, delivering tumor genes, and functioning as contrast compounds in imaging. Diverse nanomaterials derived from organic, inorganic, lipid, or glycan compounds, in addition to synthetic polymers, have been employed to advance and enhance novel cancer therapeutics. The present review centers on the utilization of nanoparticles in clinical settings for the purposes of cancer diagnosis and treatment, with a particular emphasis on their function as drug carriers and targeted therapy agents.
ISSN:2543-1064
2543-1064
DOI:10.1016/j.abst.2024.06.003